BLOG

Combining NK Cell Therapy With Standard Cancer Treatment in Japan

8 min read

Hello, I am Dr. Hidenori Shimada of Grand Green Osaka Umekita Clinic in Osaka, Japan.

When people learn about NK cell therapy, one of the first questions is practical: can it be used while I am already receiving surgery, chemotherapy, or radiation therapy? For many international patients, the concern is also about coordination. Your main cancer team may be in another country, while the immune cell therapy would be provided in Japan. This article explains how the question is generally approached, what the evidence can and cannot tell us, and what to prepare before you speak with a doctor.

The Short Answer: It Is Designed to Sit Alongside Standard Treatment

NK cell therapy is not intended to replace surgery, chemotherapy, or radiation therapy. At Grand Green Osaka Umekita Clinic, it is described as a cancer immune cell therapy that can be considered together with standard treatment, and the clinic can coordinate with the medical institution that provides your standard care. The therapy works on a different principle from those treatments, so the two are generally considered compatible, although this still needs to be checked for each patient. Whether combining them is appropriate in your case, however, is a medical judgment that depends on your cancer type, stage, current treatment plan, and overall health.

It is also important to be clear about what this does not mean. Combining therapies does not guarantee a particular result, and no responsible clinic can promise how any individual will respond. The goal of the conversation is to decide, with your doctors, whether adding an immune-focused option fits your situation.

How NK Cell Therapy Differs From Surgery, Chemotherapy, and Radiation

Surgery physically removes a tumor, radiation therapy uses focused energy to damage cancer cells in a targeted area, and chemotherapy uses drugs that act on rapidly dividing cells throughout the body. NK cell therapy takes a different route. Natural killer cells are part of the innate immune system and are known to detect and attack abnormal cells, including cancer cells and virus-infected cells. In this therapy, NK cells are collected from an ordinary blood draw, activated and expanded in a specialized cell processing facility, and then returned to your body through an intravenous infusion.

Because the cells come from your own body, the treatment is described as autologous. The aim is to reinforce immune function that may have weakened with age, stress, or the effects of the disease itself. Researchers have studied NK cell infusions in a range of clinical settings, and the results so far vary by cancer type and study design. For that reason, it is more accurate to see NK cell therapy as an option under continued investigation than as a proven answer for every patient.

Timing and Coordination: Questions Your Doctors Will Likely Consider

Timing is where individual medical judgment matters most. Chemotherapy and radiation can temporarily lower blood cell counts, and the quality and quantity of blood-derived cells may be affected by your condition on the day of collection. Your doctors may therefore consider where you are in your treatment schedule, how recent your last cycle was, and whether your blood test results are suitable for cell collection.

Questions that commonly come up in a consultation include the following:

  • Where are you in your current treatment plan, and are any procedures or new drugs scheduled?
  • Do recent blood test results and your general condition allow blood collection for cell culture?
  • Are you taking medicines, such as steroids or other immune-affecting drugs, that your doctors should review?
  • How can your Japanese clinic and your home oncologist share information so that everyone works from the same picture?

Sharing a recent summary of your diagnosis, treatment history, and test results helps the doctor give advice that is specific to you rather than general.

Safety, Side Effects, and Legal Framework in Japan

NK cell therapy in Japan is provided under the country’s regenerative medicine law, which requires clinics to have a provision plan reviewed by a certified committee and submitted to the Ministry of Health, Labour and Welfare before treatment can be offered. Cell culture is carried out at licensed cell processing facilities. This framework is meant to support careful management, but it does not remove all risk.

Because the therapy uses your own cells, the risk of rejection is considered low, and serious side effects have rarely been reported. Even so, temporary fever or fatigue may occur after an infusion, and other reactions are possible. If you are also receiving chemotherapy or radiation, it can be hard to tell which treatment is responsible for a symptom, which is another reason to keep all of your doctors informed. Please contact a doctor promptly if you feel unwell after treatment, and ask in advance whom to call, especially if you will be traveling back home.

Cost, Insurance, and What to Confirm Before You Decide

NK cell therapy is a self-pay medical service in Japan and is not covered by national health insurance. Fees, the number of infusions, treatment intervals, and risks should all be explained to you in the consultation, and you should feel free to ask for them in writing. Because plans differ from person to person, avoid relying on figures you find online and confirm the details directly with the clinic.

It can help to bring a short list of questions: what the realistic aims of the treatment are, what is not known, what would make a doctor advise against it, and how progress will be reviewed alongside your standard care. A good consultation leaves you better informed, whether or not you decide to proceed.

Getting Started From Overseas: Osaka, Umeda, and Multilingual Information

Grand Green Osaka Umekita Clinic is located in the Umeda area of Osaka, which is accessible from Kansai International Airport and from major rail lines. The clinic provides an information page for international patients, so you can review the basics in English before you make contact. If you are considering medical travel, it helps to gather your records, discuss the idea with your home oncologist first, and then arrange a consultation to look at your case in detail.

NK cell therapy can be an option to discuss alongside standard cancer treatment, but it should never be a reason to delay or skip the care your cancer team recommends. Whether it suits you can only be decided after a medical examination. If you would like to learn more, please see the NK cell therapy page for details on the flow, fees, and frequently asked questions, and consider booking a consultation.

Learn more about NK Cell Therapy

References

Supervising Physician

Hidenori Shimada

Director, Medical Corporation Shimada Clinic
Head of Clinical Practice, Grand Green Osaka Umekita Clinic

Hidenori Shimada

Graduated from the University of Tokushima Faculty of Medicine in 2005. After his initial residency, he obtained U.S. medical certification (ECFMG) and trained as a sub-intern in general surgery at the University of Washington. After completing the doctoral program at Kyoto University Graduate School of Medicine and working as a researcher at the Center for iPS Cell Research and Application (CiRA), Kyoto University, he founded Shimada Clinic in 2013. At Grand Green Osaka Umekita Clinic (https://umekitaclinic.org), he is engaged in a wide range of care, from internal medicine and pediatrics to cell therapy and aesthetic medicine.

* The physician supervision of this article covers its academic content only and does not constitute a recommendation of any specific treatment or product.

Back to article list › Back to NK Cell Therapy ›

Grand Green Osaka South Building, Gate Tower 5F 5-54 Ofuka-cho, Kita-ku, Osaka 530-0011, Japan

TEL: 06-7653-8493 FAX: 06-7635-8052

Contact